Home › Funds › Invesco Ltd › REGN
Invesco Ltd position in REGN
REGENERON PHARMACEUTICALS INC. · Health Care
Latest position (Q2 2026)3.94M sh
Reported value held$2.46B
Portfolio Weight0.21%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 484.44K | $293.17M | New |
| Q4 2021 | 588.21K | $371.47M | Add |
| Q1 2022 | 602.93K | $421.10M | Add |
| Q2 2022 | 628.19K | $371.34M | Add |
| Q3 2022 | 641.32K | $441.79M | Add |
| Q4 2022 | 692.86K | $499.89M | Add |
| Q1 2023 | 884.75K | $726.98M | Add |
| Q2 2023 | 909.06K | $653.20M | Add |
| Q3 2023 | 743.35K | $611.75M | Reduce |
| Q4 2023 | 765.01K | $671.90M | Add |
| Q1 2024 | 986.07K | $949.08M | Add |
| Q2 2024 | 916.42K | $963.19M | Reduce |
| Q3 2024 | 1.16M | $1.22B | Add |
| Q4 2024 | 864.25K | $615.63M | Reduce |
| Q1 2025 | 850.75K | $539.57M | Reduce |
| Q2 2025 | 1.08M | $564.81M | Add |
| Q3 2025 | 1.48M | $834.67M | Add |
| Q4 2025 | 1.59M | $1.23B | Add |
| Q1 2026 | 1.72M | $1.33B | Add |
| Q2 2026 | 3.94M | $2.46B | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding REGN
- Vanguard Group 9.08M sh · $7.00B · Q4 2025
- BlackRock Inc 9.11M sh · $5.68B · Q2 2026
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- JPMorgan Chase & Co 3.77M sh · $2.38B · Q2 2026
- Franklin Resources 2.77M sh · $1.73B · Q2 2026
- Geode Capital Management 2.63M sh · $1.63B · Q2 2026
- Morgan Stanley 1.40M sh · $871.53M · Q2 2026
- Goldman Sachs Group 1.33M sh · $831.98M · Q2 2026
- Bank of America Corp 1.29M sh · $805.02M · Q2 2026
- Wellington Management Group 1.27M sh · $791.95M · Q2 2026
- Norges Bank Investment Management 1.17M sh · $731.29M · Q2 2026